Macular Dystrophies

Our sense of sight is a perfect window that allows us to perceive the world, the faces of our loved ones, and all the fine details of life. However, the cellular structures located at the very center of this window, which enable sharp vision, can sometimes wear out prematurely due to coding errors in our genetic heritage. This group of genetically based eye diseases, referred to as Macular Dystrophies in medical literature, affects quality of life deeply by impairing central vision in a slow but progressive manner.

What are Macular Dystrophies?

The nerve layer covering the back inner wall of our eye is called the retina, and the millimetric area located at the exact center of this layer, responsible for sharp, colored, and detailed vision, is called the "macula" (yellow spot). Reading books, driving, threading a needle, or recognizing a person's face depends entirely on the healthy functioning of the macula.

"Dystrophy" refers to a situation where a tissue or organ is insufficiently nourished, develops genetically incorrectly, and loses function over time due to structural deterioration. Macular Dystrophies are a rare group of diseases characterized by the gradual death of light-sensitive cells (photoreceptors) and their supporting tissues in the macula, resulting entirely from genetic (hereditary) mutations, independent of aging or environmental factors. While the commonly known "Yellow Spot Disease" (Age-Related Macular Degeneration) generally affects individuals aged 60 and over, Macular Dystrophies emerge much earlier—during childhood, adolescence, or young adulthood—threatening central vision.

Common Types of Macular Dystrophy

Macular dystrophies are not a single type of disease; they are divided into many subgroups based on the mutated gene and the type of harmful material accumulating in the cells. The primary types we manage in our clinic include:

1. Stargardt Disease: The most common type of macular dystrophy, usually starting in childhood or early youth. It results from the accumulation of toxic fatty wastes called "lipofuscin" under the retina.
2. Best Disease (Vitelliform Macular Dystrophy): Caused by a mutation in the BEST1 gene. It typically manifests in childhood. During a fundus examination, a yellowish cyst or substance resembling an "egg yolk" is detected in the macula.
3. Pattern Dystrophies: Usually appearing in middle age (between 30-50). They are characterized by pigment deposits in the macula forming various patterns (reticular, butterfly-shaped, etc.).
4. Sorsby Fundus Dystrophy: A rare but aggressively progressive type linked to the TIMP3 gene. It often leads to sudden vision loss in the 30s or 40s due to abnormal new blood vessel formation and leakage under the macula.

Causes and Inheritance Patterns

Macular dystrophies are 100% genetic. The genetic mutation is primarily passed from parents to children in two ways:

1. Autosomal Resesive Inheritance: Both parents carry the mutated gene (though they are healthy themselves). The child must inherit both faulty genes to be affected (common in Stargardt).
2. Autosomal Dominant Inheritance: It is sufficient for only one parent to carry the mutated gene and be affected for the disease to pass to the child, with a 50% risk (common in Best disease and Pattern dystrophies).

What are the Symptoms?

While there are different types, all macular dystrophies cause common and specific visual complaints, usually affecting both eyes symmetrically:

1. Blurred and Decreased Central Vision: Loss of clarity in the focus point, leading to difficulty in reading and writing.
2. Dark Spot (Scotoma): A hazy, gray, or black spot appearing in the very center of the visual field.
3. Distorted and Curved Vision (Metamorphopsia): Perceiving straight lines as wavy or bent (especially in Best and Sorsby dystrophies).
4. Changes in Color Perception: Colors appearing less bright and vivid.
5. Light Adaptation Issues: A significant delay in the eyes adapting when moving from a sunny environment to a dark room.

Advanced Technology and Genetic Mapping for Definitive Diagnosis

At Dr. Ayşe Öner Clinic, world-class diagnostic methods are applied to international patients:

1. Optical Coherence Tomography (OCT): A radiation-free 3D microscopic map of the macula is created to detect thinning and cell loss millimetrically.
2. Fundus Autofluorescence (FAF): A gold standard where toxic substances like lipofuscin glow under special light to show the extent of the disease.
3. ERG and EOG: These measure the electrical responses of the retina to light. The EOG test is particularly vital for the definitive diagnosis of Best disease.
4. Comprehensive Genetic Testing: Mapping the genetic profile is now a mandatory protocol for definitive diagnosis and determining eligibility for global gene therapy trials.

Treatment and Future Horizons: Gene Therapy

Currently, there is no standard pill or surgery that completely cures all macular dystrophies. However, the goal of clinical management is to slow cellular destruction and protect existing vision.

1. Medical Management of Complications: Abnormal bleeding vessels (as seen in Sorsby) are successfully treated with anti-VEGF injections in our clinic.
2. Visual Rehabilitation: Standard of living is raised through specialized telescopic glasses, electronic magnifiers, and contrast-enhancing filters.
3. Future Treatments (Gene Therapy and Stem Cells): Macular dystrophies are at the forefront of CRISPR gene editing and stem cell research. Dr. Ayşe Öner provides visionary guidance on these next-generation treatments by following international clinical trials closely.

To map the genetic heritage in your eyes and step into the future of medicine today, contact our expert health coordinators immediately.